Investor profile
INKEF Capital has backed 41 European tech companies across 49 funding rounds between 2014 and 2026, joining rounds totalling €1.2B. Most active in Healthtech and Software. Data as of 6 Aug 2026.
Also recorded as: Inkef Capital
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Quantum Motion | UK | 2 | €184M |
| iOnctura | Switzerland | 2 | €95M |
| Precirix | Belgium | 1 | €80M |
| Urban Sports Club | Germany | 1 | €80M |
| Ambagon Therapeutics | Netherlands |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Quantum Motion | Series C | €136M | 2026-05 |
| Urban Sports Club | Other | €80M | 2021-07 |
| iOnctura | Series B | €80M | 2024-06 |
| Precirix |
| 1 |
| €75M |
| ViCentra | Netherlands | 1 | €65M |
| Silverflow | Netherlands | 3 | €64M |
| Cardior Pharmaceuticals | Germany | 1 | €64M |
| Salvia BioElectronics | Netherlands | 1 | €53M |
| ChannelEngine | Netherlands | 2 | €50M |
| TargED Biopharmaceuticals | Netherlands | 1 | €39M |
| TargED Biopharmaceutical | Netherlands | 1 | €39M |
| Castor | Netherlands | 1 | €38M |
| Happeo | Finland | 2 | €36M |
| NMD Pharma | Denmark | 1 | €35M |
| Scenic Biotech | Netherlands | 1 | €28M |
| Onward | Netherlands | 1 | €27M |
| G-Therapeutics | Netherlands | 1 | €26M |
| Bloomon | Netherlands | 2 | €24M |
| Calypso Biotech | Netherlands | 1 | €20M |
| lengoo | Germany | 1 | €17M |
| NightBalance | Netherlands | 1 | €13M |
| Draupnir Bio | Denmark | 1 | €12M |
| Aidence | Netherlands | 1 | €10M |
| InteRNA Technologies | Netherlands | 1 | €9.9M |
| Anavo Therapeutics | Netherlands | 1 | €8.5M |
| Crowdynews | Netherlands | 2 | €6.2M |
| Sentinels | Netherlands | 1 | €5.7M |
| EclecticIQ | Netherlands | 1 | €5.5M |
| Castor EDC | Netherlands | 1 | €5.3M |
| Series B |
| €80M |
| 2022-03 |
| Ambagon Therapeutics | Series A | €75M | 2022-01 |
| ViCentra | Series C | €65M | 2021-12 |
| Cardior Pharmaceuticals | Series B | €64M | 2021-08 |
| Salvia BioElectronics | Series B | €53M | 2025-05 |
| Quantum Motion | Series B | €48M | 2023-02 |
| ChannelEngine | Series B | €45M | 2022-03 |
